MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$4,055K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-1,955 -7,910
Depreciation and amortization
164 270
Provision for inventory obsolescence
33 172
Loss on disposal of property and equipment
-19 0
Stock-based compensation
530 971
Allowance for credit losses
130 156
Non-cash lease expense
20 48
Non-cash interest expense
242 472
Trade receivables
1,836 -4,413
Prepaid expenses and other assets
425 -434
Inventories
865 720
Accounts payable
328 182
Accrued expenses and other liabilities
79 -423
Net cash used in operating activities
-3,536 -1,935
Purchases of property and equipment
519 320
Net cash used in investing activities
-519 -320
Proceeds from stock option exercises
49 -
Repayment of finance lease liabilities
4 10
Contributions from non-controlling interest
0 60
Net cash provided by (used in) financing activities
45 50
Effect of exchange rates on cash
-156 -235
Net change in cash and cash equivalents
-4,166 -2,440
Cash and cash equivalents at beginning of period
31,741 -
Cash and cash equivalents at end of period
25,135 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Apyx Medical Corp (APYX)

Apyx Medical Corp (APYX)